Identification, Structure–Activity Relationships of Marine-Derived Indolocarbazoles, and a Dual PKCθ/δ Inhibitor with Potent Antipancreatic Cancer Efficacy
Jinhui Wang,Weiyang Jin,Xiaoxin Zhou,Jiaqi Li,Chengdong Xu,Zhongjun Ma,Jianan Wang,Lele Qin,Biao Zhou,Wanjing Ding,Tingting Gao,Hangping Yao,Zhe Chen
DOI: https://doi.org/10.1021/acs.jmedchem.0c01271
IF: 8.039
2020-01-01
Journal of Medicinal Chemistry
Abstract:Protein kinases C (PKCs) are a family of serine/ threonine kinases involved in various cellular processes, including proliferation, differentiation, cell survival, and apoptosis. Here, we report the identification, structure-activity relationship (SAR), and 3D-QSAR studies of 69 natural indolocarbazoles, including 15 new compounds, from marine streptomyces strains. Interestingly, we found that the chair conformational isomer of 7-oxostaurosporine (compound 15) inhibited PKC theta more potently than the corresponding boat isomer. An evaluation of kinase selectivity and antitumor efficacy revealed that 15 was a potent dual PKC theta/delta inhibitor and that it could efficiently inhibit tumor growth in pancreatic cancer (PC) by inducing cellular apoptosis and suppressing the NF-kappa B/p-P65 pathway. In addition, we demonstrated that overexpression of p-PKC delta and p-P65 was associated with poor survival rates in patients with PC, and p-PKC theta expression also showed significant positive correlations with p-PKC delta and p-P65 levels. Finally, the PC patient-derived xenograft model further confirmed the potential anti-PC efficacy of 15.